AstraZeneca board rejects sweetened takeover offer from Pfizer By Washington Examiner May 2, 2014 9:56 am FacebookTwitterEmailPrint Add Washington Examiner on Google FacebookTwitterEmailPrint LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. TagsMergers and AcquisitionsPfizerPharmaceutical Industry Related Content Magazine Inside Scoop: The Trump Doctrine, Minnesota’s Somali taxpayer swindle, loss of common culture Columnists Eos Energy announces a breakthrough in battery energy storage Senate Trump faces Venezuela war powers uncertainty as he lobbies GOP rebels Columnists Iranian protesters expose the Leftist-Islamist alliance Beltway Confidential Peace negotiations aside, Ukraine’s security guarantees are a big deal
